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Introduction: Various laboratory markers have been proposed to assess prognosis in 
myocardial infarction. Serum cortisol is one such laboratory marker. There are only few 
studies done in the recent past which prove that cortisol is a prognostic marker in 
STEMI. 
Methods: We studied a total of 168 patients who presented with STEMI and 
underwent primary percutaneous intervention (PPCI) within 12 hours of symptom 
onset between April 2016 and November 2016.  
Results: The average age of study population was 61 ± 0.12 years. Males were 
predominant (n = 132, 78.57%). 155 patients survived, whereas 13 patients died in the 
hospital. Mean syntax score was 16.65 ±5. 33 among patients who died, whereas it was 
13.11 ± 5.62 among survivors (P = 0.03). Mean cortisol was significantly higher among 
the patients who died (46.13 ± 14.61 mcg/dl) than the survivors (31.16 ± 13.16 
mcg/dl) (P = 0.003). The ROC AUC for in-hospital mortality was 0.77 (95% 
confidence interval [CI], 0.645–0.897). An optimal cut-point identified from the ROC 
curve was a random serum cortisol concentration of 33.66 mcg/dl, with corresponding 
sensitivity and specificity of 69.2 % and 64 %, respectively. At a cut-point of 29.55 
mcg/dl, sensitivity and specificity were 84.6 and 50 %, respectively. 
Conclusion: This study showed that serum cortisol level is a strong predictor of 
mortality in patients undergoing PPCI for STEMI. Levels more than 33.66 mcg/dl can 
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INTRODUCTION
ST segment elevation myocardial infarction (STEMI) is 
one of the cardiovascular diseases carrying high 
mortality. Among the subgroup in STEMI, elderly 
patients, cardiogenic shock, anterior infarction, high 
sum of ST segment elevation and right ventricular 
infarction carry a higher mortality. Various risk 
assessment scores and laboratory markers have been 
proposed to assess prognosis in myocardial infarction. 
Serum cortisol is one such laboratory marker. There are 
only few studies done in the recent past which prove that 
cortisol is a prognostic marker in STEMI. 
Serum Cortisol Level as a Predictor of In-Hospital 
Mortality in Patients Undergoing Primary 
Percutaneous Intervention for ST Segment 
Elevation Myocardial Infarction 
M Sudhakar Rao 1,*, Tom Devasia 2, Hashir Kareem 3, 
Padmakumar R 2, Ashwal A J 3 
1 MD, DM, Assistant Professor, Department of Cardiology, Kasturba Medical 
College Manipal, Manipal Academy of Higher Education (MAHE), India 
2 MD, DM, Professor, Department of Cardiology, Kasturba Medical College 
Manipal, Manipal Academy of Higher Education (MAHE), India 
3 MD, DM, Associate Professor, Department of Cardiology, Kasturba Medical 
College Manipal, Manipal Academy of Higher Education (MAHE), India 
*Corresponding author: M Sudhakar Rao, Assistant Professor, Department of
Cardiology, Kasturba Medical College Manipal, Manipal Academy of Higher 
Education (MAHE), India. Tel: +91-9902547712, E-mail: 
msudhakar88@gmail.com
DOI: 10.29252/ijcp-24650 
Rao, et al.  International Journal of Cardiovascular Practice 
42 
Serum cortisol levels increase in response to acute 
critical illness. This involves activation of hypothalamic 
pituitary adrenal axis [1]. In myocardial infarction, both 
high and low cortisol levels have been correlated with 
mortality [2-5]. Though most of the studies 
demonstrated a high cortisol level and mortality 
association [2-4], a few studies also demonstrated a low 
serum cortisol level being associated with mortality [5]. 
This study was done to correlate serum cortisol with 
mortality and determine a cut-off value of cortisol, 
which can predict mortality in patients undergoing 




A total of 168 patients presented with STEMI and 
underwent PPCI within 12 hours of symptom onset 
between April 2016 and November 2016. 
Subjects were not eligible if they had any of the following 
conditions: 
1. Steroid use 
2. Prior history of Myocardial infarction 
3. History of recent infection 
4. History suggestive of hypo/ hypercortisolism 
5. Retroviral illness 
6. History of hypothyroidism or hyperthyroidism 
 
The study protocol was approved by the ethics 
committee of the Institution and informed consent were 
obtained prior to study entry. 
Methodology 
STEMI was defined by the American College of 
Cardiology [6] as “new ST elevation as measured from 
the J-point in 2 or more contiguous leads with leads V1, 
V2, and V3 measuring at least 0.2 mV or at least 0.1 mV 
in the remaining leads. “ 
All patients received a complete physical examination, 
assessment of cor¬onary risk factors, medical histories 
and pre¬senting clinical symptoms were also recorded. 
Venous blood samples were collected when the patient 
initially presented to the emergency depart¬ment or 
intensive coronary care unit (ICCU) before PPCI. 
Serum Cortisol (in mcg/dl) and troponin T levels (in 
ng/ml) were calculated in the laboratory using electro-
chemical luminescence immunoassay (EQL). We 
correlated at- admission serum cortisol levels with in-
hospital mortality in patients with STEMI undergoing 
PPCI. 
Angiographic Analysis 
Coronary angiography was performed through the 
femoral/radial artery and the angiograms were visually 
evaluated by interventional cardiologists who were 
blinded to the study plan and to each other. A thorough 
analysis of each coronary angiography established the 
lesion location and the percentage of stenosis. Coronary 
artery disease was defined as > 50% stenosis in the 
luminal diameter in at least one major epicardial 
coronary artery. All patients underwent primary PCI to 
culprit vessel. 
The Gensini scoring system was used to define the 
severity of the CAD. This method grades the narrowing 
in the lumen of the coronary arteries as 1 for 1-25% 
stenosis, 2 for 26-50%, 4 for 51-75%, 8 for 76-90%, 16 
for 91-99%, and 32 for total occlusion. The score is then 
multiplied by a factor illustrating the importance of the 
lesion’s location. For the location scores, 5 points are 
assigned for left main lesion; 2.5 for left circumflex 
(LCX) artery and proximal left anterior descending 
(LAD); 1.5 for the mid-segment LAD and LCX; 1 for 
the distal segment of LAD and LCX, first diagonal 
branch, first obtuse marginal branch, right coronary 
artery, posterior descending artery, and intermediate 
artery; and 0.5 for the second diagonal and second 
obtuse marginal branches. 
Gensini Score Calculation: severity score × segment 
location multiplying factor X collateral adjustment 
factor [7]. 
Lesions were also categorized according to number of 
vessels involved. Grade 0 was given smooth epicardial 
arteries, Grade 0.5 to plaque < 50% diameter stenosis, 
Grade 1to single vessel disease, Grade 2 to double vessel 
disease and Grade 3 to triple vessel disease. Coronary 
lesions leading to ≥ 50% diameter stenosis in vessels ≥ 
1.5 mm was scored separately and added together to 
provide the cumulative syntax score which was 
prospectively calculated using the SYNTAX score 
calculator on the baseline diagnostic angiogram. 
Statistical Analysis 
The statistical comparisons for the quantitative variables 
describing the clinical characteristics of the groups were 
carried out using Independent sample t test and 
expressed as mean ± standard deviation. The cortisol 
levels were also plotted on an ROC curve. The area 
under the ROC (AUC) as well as the most appropriate 
cutoff cortisol levels were calculated. The most 
appropriate cutoff values were established as the ones 
with higher result of the sum of sensitivity and 
specificity. Pearson’s non parametric test was used to 
compare serum cortisol levels with Gensini and 
SYNTAX score. All statistical analysis was done using 
statistical software IBM SPSS version 23. 
RESULTS 
The average age of study population was 61 ± 0.12 years. 
Males were predominant (n = 132, 78.57%). 155 
patients survived whereas 13 patients died. Anterior wall 
MI was commoner than inferior wall MI. Mean syntax 
score was 16.65 ± 5.33 among patients who died 
whereas it was 13.11 ± 5.62 among survivors (P = 0.03) 
(Table 1). 
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Table 1. Baseline characteristics 
Variables All patients (n = 168) Survived (n = 155) Expired (n = 13) P value 
Age (years) 61 ± 0.12 61.37 ± 9.84 60.69 ± 9.52 0.812 
Male 132 (78.57) 122 (78.71) 10 (76.92) 0.895 
Female 36 (21.43) 33 (21.29) 3 (23.08) 0.880 
Diabetes mellitus 32 (19.04) 27 (17.42) 5 (38.46) 0.064 
Hypertension 41 (24.40) 35 (22.58) 6 (46.15) 0.058 
Dyslipidemia 20 (11.90) 15 (9.68) 5 (38.46) 0.002 
Smokers 21 (12.5) 15 (9.68) 6 (46.15) 0.000 
AWMI (Infarction in LAD territory) 87 (51.78) 78 (50.32) 9 (69.23) 0.191 
IWMI (Infarction in RCA or LCx territory) 81 (48.22) 77 (49.68) 4 (30.77) 0.191 
Syntax score 13.33 ± 5.57 13.11 ± 5.62 16.65 ± 5.33 0.030 
Cortisol (mcg/dl) 32.32 ± 13.83 31.16 ± 13.16 46.13 ± 14.61 0.000 
Gensini score 59.33 ± 26.51 57.27 ± 25.61 83.85 ± 25.72 0.001 
Data in table are presented as Mean ± SD or No. (%) 
(AWMI-anterior wall myocardial infarction, IWMI - inferior wall myocardial infarction, LAD – left anterior descending artery, RCA – right coronary 
artery, LCx – left circumflex artery) 
 
 
Mean cortisol was significantly higher among the 
patients who died (46.13 ± 14.61 mcg/dl) than the 
survivors (31.16 ± 13.16 mcg/dl) (P = 0.003). Mean 
cortisol level was 36.85 ± 13.09 mcg/dl in females 
whereas it was 31.09 ± 13.81 mcg/dl in males (P = 0.02). 
Mean cortisol level was 33.11 ± 14.05 in AWMI whereas 
it was 31.13±13.31 mcg/dl in IWMI (P = 0.4) 
The ROC AUC for in-hospital mortality was 0.771 
(95% confidence interval [CI], 0.645–0.897). An 
optimal cut-point identified from the ROC curve was a 
random serum cortisol concentration of 33.66 mcg/dl, 
with corresponding sensitivity and specificity of 69.2 % 
and 64 %, respectively. At a cut-point of 29.55 mcg/dl, 
sensitivity and specificity were 84.6 and 50 %, 




Figure 1. Serum cortisol levels as a predictor of mortality in patients 
with ST segment elevation myocardial infarction. ROC analysis 
revealed that area under the curve was 0.77. The cut-off value of serum 
cortisol for predicting mortality was 33.66 mcg/dl. 
 
DISCUSSION 
Our study correlated at- admission serum cortisol levels 
with mortality in patients with STEMI undergoing 
PPCI. We studied the correlation of cortisol levels with 
in-hospital mortality, age, distribution of MI and 
magnitude of coronary artery disease. Several studies 
have correlated serum cortisol levels with outcomes in 
MI [2-5, 8, 9]. However most of these studies were done 
few decades ago. To our knowledge this is the first study 
in patients with ST segment elevation MI undergoing 
PPCI correlating serum cortisol levels with in-hospital 
mortality. In-hospital mortality was 7.73 percent and 
mean cortisol level was significantly higher among the 
patients who died. In our study the cut-off for serum 
cortisol level to predict mortality was 33.66 mcg/dl, with 
corresponding sensitivity and specificity of 69.2 % and 
64 %, respectively.  
Zouaghi et al. [2] reported a negative association 
between cortisol concentration and risk of death in 34 
consecutively treated patients with acute coronary 
syndrome. Bain et al. [3] studied serum cortisol 
response to acute myocardial infarction in 70 
consecutive patients admitted to a coronary care unit 
and showed that the levels were significantly raised early 
in the course of the illness and prior to elevation of the 
cardiac specific enzyme fraction, creatine kinase MB. 
They also showed that very high levels (more than 2000 
micromole/L) were predictive of mortality. Imran Nito 
et al. [4] studied thirty-six patients with myocardial 
infarction and correlated mortality with random serum 
cortisol levels. Out of these, four patients died, whereas 
thirty-two patients survived. Serum cortisol was 
significantly higher among the patients who died than 
the survivors. In this study, death and size of myocardial 
infarction were significantly correlated with a cortisol 
level of more than 20 mcg/dl on the day of admission. 
Reynolds et al. [5] demonstrated lower serum cortisol 
levels in patients who died than those who survived 
(median, 1189 nmol/L vs. 1355 nmol/L; P < 0.001).A 
cortisol concentration in the bottom quartile (< 1136 
Rao, et al.  International Journal of Cardiovascular Practice 
44 
nmol/L) was a strong predictor of death within 30 days. 
Wiener showed that significant limit of cortisol level to 
death was found to be > 20 ug/dL. Plasma cortisol levels 
in myocardial infarctions with any complication were 
higher than in patient with infarction without any 
complication [9]. Prakash also found similar results, i.e. 
10 out of 12 acute myocardial infarction patients with 
complication had cortisol levels of > 40 ug/dL. 
In this study there was no correlation between serum 
cortisol levels with Gensini and syntax score. This 
establishes the fact that cortisol levels may predict in-
hospital mortality in STEMI independent of the extent 
or severity of coronary artery disease. However, there 
are no previous studies correlating cortisol levels with 
either syntax or Gensini score. Further studies need to 
be conducted in STEMI with larger mortality data to 
establish the relation. Also, we did not find any 
correlation between mean cortisol levels with age and 
distribution of myocardial infarction. However, females 
had a significant higher cortisol levels compared to 
males. 
Few limitations of this observational study merits 
consideration. We studied only the in-hospital mortality 
in patients undergoing primary PCI and correlated with 
serum cortisol levels and so the long term clinical 
outcomes were not studied. There is a diurnal variation 
in serum cortisol levels with levels being highest in 
morning and lowest at mid-night. The appropriate time 
to measure cortisol levels following stress remains 
uncertain. Though many studies conducted shows that 
cortisol response following acute stress is blunted, it still 
remains controversial. So further studies are required to 
study the diurnal variation in cortisol levels following 
STEMI. 
CONCLUSION 
In our study we showed that serum cortisol level is a 
strong predictor of in-hospital mortality in patients 
undergoing PPCI for STEMI. Levels more than 33.66 
mcg/dl can predict mortality with a sensitivity of almost 
70 percent and specificity of 64 percent.  
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